ASMLvsJNJ
ASML Holding NV vs Johnson & Johnson. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.
ASML Holding NV
$1,443.66
+28.57%
Johnson & Johnson
$226.16
+9.50%
60-day price, rebased to 100
Round-by-round
Valuation upside
-61.20% vs -36.40% to DCF fair value
Balance-sheet strength
Altman Z 13.05 vs 5.08
Fundamental quality
Piotroski 8.00 vs 4.00 (of 9)
Growth + margins
Rule-of-40 49.30 vs 26.60
60-day momentum
-0.75% vs +2.11% price return
Market-cap liquidity
$569.1B vs $585.7B
Verdict
Across 6 categories, ASML takes the edge with 3 wins to 2 (and 1 tie). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.
Backtest a strategy on ASML or JNJ
Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.